Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting cancer-related enzymes such as PI3K and mTOR. Its structure supports high selectivity and binding affinity, making it valuable in developing targeted therapies for oncology. Also explored in the design of CNS-active compounds due to its ability to cross the blood-brain barrier.